• WORLD
    • EUROPE
    • AMERICA
    • AFRICA
    • ASIA PACIFIC
  • ENTERTAINMENT
    • CINEMA
    • MUSIC
    • TV & WEB
  • SCIENCE
  • TECHNOLOGY
  • SPORTS
    • FOOTBALL
    • MOTORSPORT
    • NBA
    • NFL
    • TENNIS
What's Hot

A letter from the Super League to Ufa and Feifei was leaked

Upcoming important UEFA press conference will respond to the Premier League

Despite the R value of 1.14, Switzerland is still relaxed: “Barbecue with colleagues”

Facebook Twitter Instagram
NewsLine
  • WORLD
    • EUROPE
    • AMERICA
    • AFRICA
    • ASIA PACIFIC
  • ENTERTAINMENT
    • CINEMA
    • MUSIC
    • TV & WEB
  • SCIENCE
  • TECHNOLOGY
  • SPORTS
    • FOOTBALL
    • MOTORSPORT
    • NBA
    • NFL
    • TENNIS
Subscribe
NewsLine
Home»WORLD»30 years later, scientists have finally embarked on the AIDS vaccine track
WORLD

30 years later, scientists have finally embarked on the AIDS vaccine track

April 8, 2021No Comments3 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
30 years later, scientists have finally embarked on the AIDS vaccine track
Share
Facebook Twitter LinkedIn WhatsApp Pinterest Email

After more than 30 years of attempts, the search for an HIV vaccine may have made gratifying progress. If it is not treated in time, the vaccine can cause AIDS. ABC News reported that preliminary data from early clinical trials conducted by the International AIDS Vaccine Initiative (IAVI) and the Scripps Research Institute in La Jolla, California indicate that this new HIV vaccine is promising.

“These are very early studies, but they are still very interesting.” William Schaffner, a professor of preventive medicine and infectious disease at Vanderbilt University in Nashville, did not participate in the clinical trial.

Although it may be necessary to further test potential vaccines in larger studies, experts hope that this vaccine will succeed if other vaccines fail.

Schaffner said: “This is a very novel approach to vaccine development,” he described basic vaccine technology as the frontier science of the 21st century.

When it was discovered in the early 1980s that HIV was the cause of AIDS, researchers believed that vaccines against this virus would be discovered soon, as would diseases such as measles, chickenpox and hepatitis B. In addition, the then US Secretary of Health Margaret Heckler (Margaret Heckler) predicted in 1984 that the vaccine would be on the market within two years. The researchers soon discovered that there were more obstacles than they initially thought.

HIV is a rapidly mutating virus, so it has become a moving target for vaccines. HIV also has many different subtypes, so a vaccine that provides protection against one subtype of HIV may not be effective against another subtype. The new research aims to solve these difficulties by developing a vaccine that can help the body produce a wide range of neutralizing antibodies. Researchers hope that it can stimulate the human immune system to resist multiple HIV strains and mutations.

CEO Dr. Mark Feinberg said: “The basis of this study is to identify a subset of HIV-infected individuals who produce so-called broadly neutralizing antibodies during the course of infection. This basically means that these antibodies can effectively block the development of different HIV strains. Infection.” IAVI

A phase 1 clinical trial that is still in progress includes 48 healthy adults who received two doses of the vaccine or placebo two months apart. Preliminary data shows that 97% of vaccinated people initially show signs that their immune system can produce the aforementioned broad range of antibodies.

Schaffner said: “Broadly neutralizing antibodies are important because this virus can mutate so quickly that infected people need guns instead of ordinary rifles to prevent a large number of different types of HIV.” HIV vaccines The research and development is in sharp contrast to the research and development of the covid-19 vaccine. The research and development of the covid-19 vaccine is gaining momentum and we are trying to develop more vaccines soon.

Researchers at IAVI and Scripps are collaborating with companies such as Moderna to consider mRNA technology for covid-19 vaccine development. Although the potential HIV vaccines being studied in this study are not based on mRNA technology, researchers are considering how to use this technology to develop HIV vaccines in the future, ABC News concluded.

.

#AIDS #AIDS virus #HIV vaccine #vaccine
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

Despite the R value of 1.14, Switzerland is still relaxed: “Barbecue with colleagues”

April 19, 2021

Greece has cancelled compulsory quarantine measures for people from the European Union and five other countries (but not all)

April 19, 2021

American otters are optimistic about the crown

April 19, 2021

After the establishment of the Duclert Committee, Kigali published his own report on France’s responsibility for the genocide in Rwanda

April 19, 2021
Add A Comment

Leave A Reply Cancel Reply

You must be logged in to post a comment.

BREAKING NEWS

FOOTBALL

A letter from the Super League to Ufa and Feifei was leaked

April 19, 2021
SPORTS

Upcoming important UEFA press conference will respond to the Premier League

April 19, 2021
WORLD

Despite the R value of 1.14, Switzerland is still relaxed: “Barbecue with colleagues”

April 19, 2021

Subscribe to Updates

Get the latest sports news from SportsSite about soccer, football and tennis.

Advertisement
NEWSLINE

Newsline.news is an Internet-based news site, which takes advantage of technological and community-building opportunities for the supply of digital news to readers.

Facebook Twitter Instagram Pinterest YouTube

Subscribe to Updates

Get the latest news from Newsline

© 2021 ThemeSphere. Designed by ThemeSphere.
  • Home
  • Buy Now

Type above and press Enter to search. Press Esc to cancel.